Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeutic extravasations

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 64, Issue 2, 2011, Pages 240-247

  Steiert, A ^a   Hille, U ^a   Burke, W ^a   Gohritz, A ^a   Zilz, S ^a   Herold, C ^a   Vogt, P M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chemotherapy; Extravasation injury; Soft tissue damage; Subcutaneous wash out procedure

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; EPIRUBICIN; NAVELBINE; PACLITAXEL; TRASTUZUMAB;

ADULT; AGED; ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE EXTRAVASATION; MINIMALLY INVASIVE SURGERY; PRIORITY JOURNAL; SKIN INFLAMMATION; SUBCUTANEOUS TISSUE; SUBCUTANEOUS WASH OUT PROCEDURE; SURGICAL APPROACH; SURGICAL TECHNIQUE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; SUBCUTANEOUS TISSUE; THERAPEUTIC IRRIGATION;

EID: 78650717028     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2010.04.040     Document Type: Article

References (56)

1. R.A. Ener, S.B. Meglathery, and M. Styler Extravasation of systemic hemato-oncological therapies Ann.Oncol 15 2004 Jun 858 862
2. D.L. Schrijvers Extravasation: a dreaded complication of chemotherapy Ann.Oncol 14 2003 iii26 iii30
3. M. Baur, H.R. Kienzer, and T. Rath Extravasation of Oxaliplatin (Eloxatin(R)) - Clinical Course Onkologie 23 2000 Oct 468 471
4. T. Quintanar Verduguez, A. Blanco Jarava, and M.B. Martinez-Barbeito Mediastinal extravasation of doxorubicin Clin.Transl.Oncol 10 2008 Feb 128 130
5. F. D'Andrea, M.G. Onesti, and G.F. Nicoletti Surgical treatment of ulcers caused by extravasation of cytotoxic drugs Scand.J.Plast.Reconstr.Surg. Hand Surg 38 2004 288 292
6. D.L. Larson Alterations in wound healing secondary to infusion injury Clin.Plast.Surg 17 1990 Jul 509 517
7. P. Preuss, and S. Partoft Cytostatic extravasations Ann.Plast.Surg 19 1987 Oct 323 329
8. W.U. Batzler, K. Giersiepen, S. Hentschel, Krebs in Deutschland 2003-2004. Häufigkeiten und Trends 6. Auflage 2008 Berlin
9. J. Considine, P. Livingston, and T. Bucknall A review of the role of emergency nurses in management of chemotherapy-related complications J.Clin.Nurs 18 18 2009 Sep 2649 2655
10. R.T. Dorr, D.D. van Hoff, Cancer chemotherapy handbook 2nd ed 1993 Appleton and Lange Norwalk (Conneticut)
11. W.E. Berdel, H.J. Schmoll, T. Büchele, W. Dempke, Kompendium Internistische Onkologie 3Aufl. 1999 Springer Verlag Berlin
12. C. Heitmann, C. Durmus, and G. Ingianni Surgical management after doxorubicin and epirubicin extravasation J.Hand Surg.Br. 23 1998 Oct 666 668
13. K. Jordan, T. Behlendorf, and A. Surov Venous access ports: frequency and management of complications in oncology patients Onkologie 31 2008 Jul 404 410
14. L. Schulmeister Vesicant chemotherapy extravasation antidotes and treatments Clin.J.Oncol.Nurs 13 2009 Aug 395 398
15. H.T. Mouridsen, S.W. Langer, and J. Buter Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies Ann.Oncol 18 2007 Mar 546 550
16. K.C. Kahler, D. Mustroph, and A. Hauschild Current recommendations for prevention and therapy of extravasation reactions in dermato-oncology J.Dtsch.Dermatol.Ges 7 2009 Jan 21 28
17. I. Kraemer, and M. Stuetzle Zytostatika-Paravasation - Wie ist vorzugehen? Krankenhauspharmazie 23 2002 261
18. L. Rinnab, M. Ringhoffer, and R. Mayer-Steinacker Prevention, early diagnosis and treatment of chemoextravasation. Practical management in the uro-oncological practice Urologe A 48 2009 Nov 1283 1284 1286-90, 1292-4
19. C. Pericay, A. Lopez, and J.R. Soler Extravasation of oxaliplatin: an infrequent and irritant toxicity Clin.Transl.Oncol 11 2009 Feb 114 116
20. T.V. Goolsby, and F.A. Lombardo Extravasation of chemotherapeutic agents: prevention and treatment Semin.Oncol 33 2006 Feb 139 143
21. U. Kunzmann, M.P. Lux, and S. Krebs Paravasatbildung bei aggressiver Chemotherapie, trotz korrekt platzierten Veneverweilkatheters Senologie 3 2009 177 214
22. I. Mader Paravasate von Zytostatika 2002 110
23. D.T. Gault Extravasation injuries Br.J.Plast.Surg 46 1993 Mar 91 96
24. R. Giunta, J. Akpaloo, and L. Kovacs Subcutaneous 'wash-out' in extravasations Handchir.Mikrochir.Plast.Chir 34 2002 Nov 399 402
25. P. Napoli, B. Corradino, and G. Badalamenti Surgical treatment of extravasation injuries J.Surg.Oncol 91 2005 Sep 15 264 268 discussion 268-9
26. P. Telisselis, G. Heers, and B. Plock Emergency open surgical treatment of extravasations of cytostatic agents in the upper extremity Handchir.Mikrochir.Plast.Chir 2009 Nov 3
27. S. Vano-Galvan, and P. Jaen Images in clinical medicine. Extravasation of epirubicin N.Engl.J.Med 360 2009 May 14 2117
28. I. Kraemer Zytostatika-Paravasate-Set Krankenhauspharmazie 13 1992 154 157
29. J. Barth Zytostatikaherstellung in der Apotheke 2003 DAV Stuttgart VI(3)
30. J. Barth, and M. Kloke Seeber, Schütte. Therapiekonzepte Onkologie 4.Aufl 2003
31. R. van Gemmen Gewebstoxizität und Paravasatbehandlung neuer Zytostatika Krankenhauspharmazie 17 10 1996 471
32. M. Allwood, A. Stanley, P. Wright, The cytotoxic handbook 3rd ed. 1997 Oxford and New York
33. th ed 1993 J.B. Lippincott Company
34. U. Riedel, M. Serke, and N. Schönfeld Extravasation of paclitaxel- clinical course Onkologie 22 1999 318
35. J.A. Ajani, L.G. Dodd, and K. Daugherty Taxol-induced soft-tissue injury secondary to extravasation: characterization by histopathology and clinical course J. Natl. Cancer Inst 86 1994 Jan 5 51 53
36. G. Schneider Paravasate von Zytostatika- Diagnostik und Therapie 6.Aufl 1999
37. R.T. Dorr Antidotes to vesicant chemotherapy extravasations Blood Rev. 4 1990 Mar 41 60
38. A. Kraft, S. Weinig, and M. Edinger Anthracyclin-Extravasate- Behandlungsrichtlinien und Literaturübersicht Der Onkologe 6 2000 674
39. S. Madhavan, and D.W. Northfelt Lack of vesicant injury following extravasation of liposomal doxorubicin J. Natl. Cancer Inst 87 1995 Oct 18 1556 1557
40. S. Cabriales, J. Bresnahan, and D. Testa Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases Oncol.Nurs. Forum 25 1998 Jan-Feb 67 70
41. J. Lokich Doxil extravasation injury: a case report Ann.Oncol 10 1999 Jun 735 736
42. S. Mullin, M.C. Beckwith, and L.S. Tyler Prevention and management of antineoplastic extravasation injury Hosp Pharm 35 2000 57
43. G. Bertelli, A. Gozza, and G.B. Forno Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study J.Clin.Oncol 13 1995 Nov 2851 2855
44. D. Comas, and J. Mateu Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion Ann.Pharmacother 30 1996 Mar 244 246
45. R.S. Marnocha, and P.R. Hutson Intradermal carboplatin and ifosfamide extravasation in the mouse Cancer 70 1992 Aug 15 850 853
46. O. Bairey, J. Bishara, and B. Stahl Severe tissue necrosis after cisplatin extravasation at low concentration: possible 'immediate recall phenomenon' J. Natl. Cancer Inst 89 1997 Aug 20 1233 1234
47. J. Albanell, and J. Baselga Systemic therapy emergencies Semin.Oncol 27 2000 Jun 347 361
48. J. Raley, J.P. Geisler, and T.E. Buekers Docetaxel extravasation causing significant delayed tissue injury Gynecol.Oncol 78 2000 Aug 259 260
49. L. Lebredo, R. Barrie, and E.A. Woltering DMSO protects against adriamycin-induced tissue necrosis J.Surg.Res. 53 1992 Jul 62 65
50. H. Hajarizadeh, L. Lebredo, and R. Barrie Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig Ann.Surg.Oncol 1 1994 Sep 411 414
51. H.J. Lawrence, D. Walsh, and K.A. Zapotowski Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation Cancer Chemother.Pharmacol 23 1989 316 318
52. I.N. Olver, J. Aisner, and A. Hament A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation J.Clin.Oncol 6 1988 Nov 1732 1735
53. G. Bertelli Prevention and management of extravasation of cytotoxic drugs Drug Saf 12 1995 Apr 245 255
54. D.S. Alberts, and R.T. Dorr Case report: topical DMSO for mitomycin-C-induced skin ulceration Oncol.Nurs. Forum 18 1991 May-Jun 693 695
55. J. Pattison Managing cytotoxic extravasation Nurs. Times 98 2002 Oct 29-Nov 4 32 34
56. B.L. Stanford, and F. Hardwicke A review of clinical experience with paclitaxel extravasations Support. Care Cancer 11 2003 May 270 277